Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-19

FDA Approved: LACOSAMIDE ORAL SOLUTION — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved an ANDA for lacosamide oral solution from Ascend Laboratories, LLC. This generic formulation is intended for use in treating partial-onset seiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide oral solution (lacosamide)

Snippet

ORIG AP for LACOSAMIDE ORAL SOLUTION (LACOSAMIDE ORAL SOLUTION)